pharma · Colorectal Cancer · Cancer · GDTC
CytoMed Therapeutics
CytoMed Therapeutics Ltd
CytoMed Therapeutics is a pharma organization headquartered in 1 COMMONWEALTH LANE, U0, SG. It trades on NYSE under ticker GDTC. Primary therapeutic focus areas include Colorectal Cancer, Cancer, Aging Well, Lupus Nephri
Company details
- Status
- Public
- HQ
- 1 COMMONWEALTH LANE, U0, SG
- Founded
- 2018
- Employees
- 26
- Programs
- 4
- Drugs
- 12
- Patents
- 3
Human Umbilical Cord derived MSCs
Phase 2 · mab · Lupus Nephritis
Human Umbilical Cord derived MSCs for Lupus Nephritis is a Phase 2 program (mab) at CytoMed Therapeutics Ltd with 1 ClinicalTrials.gov record(s).
Internal code CT 11-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CytoMed Therapeutics Ltd
- Phase
- Phase 2
- Modality
- mab
- Indication
- Lupus Nephritis
- Status
- active
- Trials
- 1